These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Pharmacokinetic/pharmacodynamic relationship of the duration of vasodilating action of organic mononitrates in rats. Tzeng TB; Fung HL J Pharmacol Exp Ther; 1992 May; 261(2):692-700. PubMed ID: 1578380 [TBL] [Abstract][Full Text] [Related]
10. Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man. Laufen H; Aumann M; Leitold M Arzneimittelforschung; 1983; 33(7):980-4. PubMed ID: 6684933 [TBL] [Abstract][Full Text] [Related]
11. Concentrations of isosorbide dinitrate, isosorbide-2-mononitrate and isosorbide-5-mononitrate in human vascular and muscle tissue under steady-state conditions. Schneider W; Menke G; Heidemann R; Satter P; Kaltenbach M; Rietbrock N Eur J Clin Pharmacol; 1990; 38(2):145-7. PubMed ID: 2338111 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of isosorbide mononitrate. Abshagen UW Am J Cardiol; 1992 Nov; 70(17):61G-66G. PubMed ID: 1449102 [TBL] [Abstract][Full Text] [Related]
13. Isosorbide, isomannide and isoidide dinitrate: urinary excretion in the rat. Rosseel MT; Bogaert MG Biochem Pharmacol; 1973 Jan; 22(1):67-72. PubMed ID: 4763246 [No Abstract] [Full Text] [Related]
14. Determination of isosorbide dinitrate and its mononitrate metabolites in human plasma using Extrelut purification and capillary column gas-liquid chromatography. Santoni Y; Rolland PH; Cano JP J Chromatogr; 1984 Mar; 306():165-72. PubMed ID: 6715456 [TBL] [Abstract][Full Text] [Related]
15. Sex-related differences in the pharmacokinetics of isosorbide-5-mononitrate (60 mg) after repeated oral administration of two different original prolonged release formulations. Vree TB; Dammers E; Valducci R Int J Clin Pharmacol Ther; 2004 Aug; 42(8):463-72. PubMed ID: 15366327 [TBL] [Abstract][Full Text] [Related]
16. [Determination of isosorbide-5-mononitrate in plasma by GC-ECD and study on its pharmacokinetics in ten volunteers]. Yang LL; Yuan YS; Zhao FL Yao Xue Xue Bao; 1997 Oct; 32(10):773-6. PubMed ID: 11596222 [TBL] [Abstract][Full Text] [Related]
17. [Gas chromatographic method with EC detection to determine isosorbide-5-mononitrate (IS-5-MN) in human serum and its pharmacokinetic parameters]. Xia GZ; Fu YK; Dong SN; Li R Yao Xue Xue Bao; 1994; 29(8):634-8. PubMed ID: 7985521 [TBL] [Abstract][Full Text] [Related]
18. Isosorbide 5-mononitrate pharmacokinetics in humans. Taylor T; Chasseaud LF; Major R; Doyle E; Darragh A Biopharm Drug Dispos; 1981; 2(3):255-63. PubMed ID: 7295882 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration. Abshagen U; Betzien G; Endele R; Kaufmann B; Neugebauer G Eur J Clin Pharmacol; 1985; 27(6):637-44. PubMed ID: 3987768 [TBL] [Abstract][Full Text] [Related]
20. Effect of penetration enhancers on isosorbide dinitrate penetration through rat skin from a transdermal therapeutic system. Gabiga H; Cal K; Janicki S Int J Pharm; 2000 Apr; 199(1):1-6. PubMed ID: 10794921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]